Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

The pharmaceutical supply chain is a sector infamous for glacially slow adjustments, lackluster reform, lack of transparency ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Congress missed a chance at PBM reforms.

The time is right for PBM reform, but the American people might be better served if Congress goes back to the drawing board ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...